Difficultés thérapeutiques lors de la prise en charge des infections à staphylocoque résistant à la méticilline
作者： W M
DOI: 10.1016/S1624-0693(02)00304-3
关键词:
摘要: Glycopeptides remain the cornerstone of treatment severe infections caused by methicillin resistant S. aureus. Therapeutic failures may be due to failure removing intravascular device, or presence secondary foci such as endocarditis. Up now, pharmacological were rather uncommon provided that adequate serum levels are obtained. However, emergence glycopeptide intermediate aureus (GISA) strains lead an increased risk failure. In patients infected with GISA strains, high glycopeptides should maintained. For these combination therapy also investigated. © 2002 Editions scientifiques et medicales Elsevier SAS / therapeutic
srlf.org 
sci-hub.se 参考文章(20)
Vance G Fowler, Jennifer Li, G Ralph Corey, Jerry Boley, Kieren A Marr, Ajay K Gopal, Li Kuo Kong, Geoffrey Gottlieb, Carolyn L Donovan, Daniel J Sexton, Thomas Ryan, None, Role of Echocardiography in Evaluation of Patients With Staphylococcus aureusBacteremia: Experience in 103 Patients Journal of the American College of Cardiology. ,vol. 30, pp. 1072- 1078 ,(1997) , 10.1016/S0735-1097(97)00250-7
A. Soriano, J. A. Martinez, J. Mensa, F. Marco, M. Almela, A. Moreno-Martinez, F. Sanchez, I. Munoz, M. T. Jimenez de Anta, E. Soriano, Pathogenic Significance of Methicillin Resistance for Patients with Staphylococcus aureus Bacteremia Clinical Infectious Diseases. ,vol. 30, pp. 368- 373 ,(2000) , 10.1086/313650
A L Graziani, L A Lawson, G A Gibson, M A Steinberg, R R MacGregor, Vancomycin concentrations in infected and noninfected human bone. Antimicrobial Agents and Chemotherapy. ,vol. 32, pp. 1320- 1322 ,(1988) , 10.1128/AAC.32.9.1320
P. Calain, K.-H. Krause, P. Vaudaux, R. Auckenthaler, D. Lew, F. Waldvogel, B. Hirschel, Early Termination of a Prospective, Randomized Trial Comparing Teicoplanin and Flucloxacillin for Treating Severe Staphylococcal Infections The Journal of Infectious Diseases. ,vol. 155, pp. 187- 191 ,(1987) , 10.1093/INFDIS/155.2.187
Fred C Tenover, James W Biddle, Michael V Lancaster, Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerging Infectious Diseases. ,vol. 7, pp. 327- 332 ,(2001) , 10.3201/EID0702.010237
H. Georges, O. Leroy, S. Alfandari, B. Guery, M. Roussel-Delvallez, C. Dhennain, G. Beaucaire, Pulmonary disposition of vancomycin in critically ill patients European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 16, pp. 385- 388 ,(1997) , 10.1007/BF01726369
V. G. Fowler, L. L. Sanders, D. J. Sexton, L. Kong, K. A. Marr, A. K. Gopal, G. Gottlieb, R. S. McClelland, G. R. Corey, Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clinical Infectious Diseases. ,vol. 27, pp. 478- 486 ,(1998) , 10.1086/514686
I. I. Raad, M. F. Sabbagh, Optimal Duration of Therapy for Catheter-Related Staphylococcus aureus Bacteremia: A Study of 55 Cases and Review Clinical Infectious Diseases. ,vol. 14, pp. 75- 82 ,(1992) , 10.1093/CLINIDS/14.1.75
Amelia Sánchez, Jesús López-Herce, Elisa Cueto, Angel Carrillo, Ramón Moral, Teicoplanin pharmacokinetics in critically ill paediatric patients Journal of Antimicrobial Chemotherapy. ,vol. 44, pp. 407- 409 ,(1999) , 10.1093/JAC/44.3.407
Marc Wysocki, Frederique Delatour, François Faurisson, Alain Rauss, Yves Pean, Benoit Misset, Frank Thomas, Jean-François Timsit, Thomas Similowski, Herve Mentec, Laurence Mier, Didier Dreyfuss, Study Group†, Continuous versus Intermittent Infusion of Vancomycin in Severe Staphylococcal Infections: Prospective Multicenter Randomized Study Antimicrobial Agents and Chemotherapy. ,vol. 45, pp. 2460- 2467 ,(2001) , 10.1128/AAC.45.9.2460-2467.2001